Glucagon degradation by human mononuclear cells.

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Glucagon is a key hormone regulating glucose metabolism.
• Understanding glucagon degradation is crucial for metabolic research.
• The role of specific human immune cells in glucagon metabolism is not fully elucidated.

Purpose of the Study:

• To investigate the degradation of iodoglucagon by human mononuclear cells.
• To identify the specific cell type responsible for glucagon degradation.
• To characterize the enzymatic properties and cellular localization of glucagon degradation.

Main Methods:

• Incubation of 125I-iodoglucagon with human mononuclear cell preparations (monocytes and lymphocytes).
• Assessment of glucagon degradation via trichloroacetic acid solubility and immunoprecipitation.
• Subcellular fractionation and kinetic analyses (Km values) to determine enzyme characteristics.
• Inhibitor studies to identify enzyme type and localization.

Main Results:

• Lymphocyte preparations did not degrade glucagon.
• Monocyte-containing preparations significantly degraded glucagon, with increased activity over time.
• Degradation activity increased with temperature (4°C to 37°C) in both intact monocytes and homogenates.
• The primary glucagon-degrading activity was localized in the cytosol (100,000 g supernatant).
• Kinetic analysis revealed specific Km values for intact cells, homogenates, and cytosol.
• Inhibitor studies suggested a sulfhydryl-dependent enzyme mediates glucagon degradation.

Conclusions:

• Monocytes are the primary cells responsible for glucagon degradation within human mononuclear cell preparations.
• Glucagon degradation by monocytes is mediated by a neutral proteolytic enzyme.
• This enzyme is predominantly located in the cell's cytosol.
• The findings provide insights into the metabolic fate of glucagon in the human immune system.